Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery

BackgroundAxillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication...

Full description

Bibliographic Details
Published in:WORLD JOURNAL OF SURGERY
Main Authors: Isahak, Mohamed Izzad; Abdullah, Muhammad Safwan; Awang, Raflis Ruzairee; Rashid, Nor Faezan Abdul; Md Sikin, Seniyah; Suhaimi, Shahrun Niza Abdullah; Abdullah, Norlia; Muhammad, Rohaizak; Md Latar, Nani Harlina
Format: Article; Early Access
Language:English
Published: WILEY 2024
Subjects:
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001197141400001
author Isahak
Mohamed Izzad; Abdullah
Muhammad Safwan; Awang
Raflis Ruzairee; Rashid
Nor Faezan Abdul; Md Sikin
Seniyah; Suhaimi
Shahrun Niza Abdullah; Abdullah
Norlia; Muhammad
Rohaizak; Md Latar
Nani Harlina
spellingShingle Isahak
Mohamed Izzad; Abdullah
Muhammad Safwan; Awang
Raflis Ruzairee; Rashid
Nor Faezan Abdul; Md Sikin
Seniyah; Suhaimi
Shahrun Niza Abdullah; Abdullah
Norlia; Muhammad
Rohaizak; Md Latar
Nani Harlina
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
Surgery
author_facet Isahak
Mohamed Izzad; Abdullah
Muhammad Safwan; Awang
Raflis Ruzairee; Rashid
Nor Faezan Abdul; Md Sikin
Seniyah; Suhaimi
Shahrun Niza Abdullah; Abdullah
Norlia; Muhammad
Rohaizak; Md Latar
Nani Harlina
author_sort Isahak
spelling Isahak, Mohamed Izzad; Abdullah, Muhammad Safwan; Awang, Raflis Ruzairee; Rashid, Nor Faezan Abdul; Md Sikin, Seniyah; Suhaimi, Shahrun Niza Abdullah; Abdullah, Norlia; Muhammad, Rohaizak; Md Latar, Nani Harlina
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
WORLD JOURNAL OF SURGERY
English
Article; Early Access
BackgroundAxillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.MethodA prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).ResultsGroup A exhibited a marginally higher mean total drain output (398 +/- 205 vs. 326 +/- 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/- 3.0 vs. 6 +/- 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/- 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/- 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.ConclusionIn conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding.
WILEY
0364-2313
1432-2323
2024


10.1002/wjs.12134
Surgery

WOS:001197141400001
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001197141400001
title Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_short Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_full Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_fullStr Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_full_unstemmed Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
title_sort Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
container_title WORLD JOURNAL OF SURGERY
language English
format Article; Early Access
description BackgroundAxillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.MethodA prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).ResultsGroup A exhibited a marginally higher mean total drain output (398 +/- 205 vs. 326 +/- 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/- 3.0 vs. 6 +/- 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/- 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/- 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.ConclusionIn conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding.
publisher WILEY
issn 0364-2313
1432-2323
publishDate 2024
container_volume
container_issue
doi_str_mv 10.1002/wjs.12134
topic Surgery
topic_facet Surgery
accesstype
id WOS:001197141400001
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001197141400001
record_format wos
collection Web of Science (WoS)
_version_ 1809678907096432640